Figure S2 from A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy

Abstract

Summary of toxicity data from 177Lu SADA-PRIT experiment against a neuroblastoma cell line